News of serious side effects in one participant of AstraZeneca's Covid-19 vaccine trial led some volunteers in Johnson & Johnson's vaccine trial in Spain to drop out, its lead investigator told Reuters on Tuesday. Still, the trial had sufficient reserve volunteers to carry on as normal, lead investigator Alberto Borobia said. AstraZeneca's Covid-19 vaccine trial was placed on hold globally on 6 September after a serious side effect was reported in a trial participant in the UK. Johnson & Johnson's Belgian Janssen unit began Phase II trials of its Covid-19 vaccine in Spain on Monday, to be carried out on 190 people and concluded on 22 September. Trials are also being carried out in the Netherlands and Germany, coming to 550 participants in total.

Source: News 24 September 15, 2020 18:25 UTC